Desjardins Global Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$1.3M Sell
2,453
-806
-25% -$390K 0.14% 158
2023
Q3
$1.65M Sell
3,259
-42
-1% -$22.4K 0.18% 134
2023
Q2
$1.72M Buy
3,301
+746
+29% +$403K 0.2% 118
2023
Q1
$1.47M Buy
2,555
+1,667
+188% +$940K 0.19% 111
2022
Q4
$488K Sell
888
-900
-50% -$477K 0.08% 219
2022
Q3
$907K Hold
1,788
0.11% 168
2022
Q2
$971K Sell
1,788
-947
-35% -$521K 0.13% 156
2022
Q1
$1.61M Sell
2,735
-22,199
-89% -$12.8M 0.14% 151
2021
Q4
$16.6M Buy
+24,934
New +$15.6M 1.42% 6

Other funds holding TMO

Desjardins Global Asset Management's TMO Position: Q4 2023 in Review

Desjardins Global Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 25% in Q4 2023, selling an estimated $390K and leaving 2,453 shares worth $1.3M. The position accounts for 0.14% of the portfolio, ranked #158.

Desjardins Global Asset Management first reported a position in TMO in Q4 2021 and has held it in 9 quarters since. The position peaked at $16.6M in Q4 2021. 2,487 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

  • Desjardins Global Asset Management held 2,453 shares of Thermo Fisher Scientific worth $1.3M as of Q4 2023.
  • Desjardins Global Asset Management sold 806 Thermo Fisher Scientific shares in Q4 2023, an estimated $390K.
  • Thermo Fisher Scientific made up 0.14% of Desjardins Global Asset Management's portfolio in Q4 2023, its #158 holding.
  • Desjardins Global Asset Management first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 9 quarters since.
  • Desjardins Global Asset Management's Thermo Fisher Scientific position peaked at $16.6M in Q4 2021.
  • 2,487 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.